Orion Group Holdings (ORN) news
Recent news
Orion - reaffirms 2026 adj EBITDA guidance range $170-$210 mln
Orion Group Holdings, Inc. (NYSE: ORN) has reaffirmed its 2026 adjusted EBITDA guidance range of $170–$210 million, reflecting confidence in its long-term growth trajectory and operational performance. The company reported second-quarter 2026 results on July 28, 2026, showing a 8% increase compared…
AInvest Wire · Aug 5, 2026Orion Group Holdings outlook FY revenue USD 900-950 million
AInvest Wire · Jul 28, 2026Orion Group Holdings Q2 EPS USD -0.1
AInvest Wire · Jul 28, 2026Orion Holdings Corp - to buy 82.5 bln won worth of shares in Ligachem Biosciences
Orion Holdings Corp has announced the completion of its acquisition of shares in Ligachem Biosciences, a South Korean biotechnology firm specializing in antibody-drug conjugate (ADC) development. The company paid 548.5 billion won ($407 million) to acquire 25.37 percent stake in Ligachem , making…
AInvest Wire · Jun 25, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.